SP1 and metabolic dysfunction-associated steatotic liver disease: It is well‐established that Sp1 acts as a transcription factor for MUC1 and is also a critical regulator of NAFLD progression.[20] This explains why no significant differences were observed in Sp1 expression or activation between WD‐fed miceWT and miceC70‐KO.